Table Filtering
Submissions
GlyTouCan
Glycan Structure Repository
GlyComb
Glycoconjugate Repository
GlycoPOST
Glycomics MS raw data Repository
UniCarb-DR
Glycomics MS Repository for glycan annotations from GlycoWorkbench
LM-GlycoRepo
Repository for lectin-assisted multimodality data
All Resources
Genes / Proteins / Lipids Glycans / Glycoconjugates Glycomes Pathways / Interactions / Diseases / Organisms
GlycoNAVI Proteins
GlycoNAVI-Proteins is dataset of glycan and protein information. This is the content of GlycoNAVI.
| Source | Last Updated |
|---|---|
| GlycoNAVI Proteins | December 18, 2024 |
| PDB ID | UniProt ID | Title ▲ | Descriptor |
|---|---|---|---|
| 3UJI | P05877 | Crystal structure of anti-HIV-1 V3 Fab 2558 in complex with MN peptide | |
| 6DB6 | 6DB6 | Crystal structure of anti-HIV-1 V3 Fab 311-11D in complex with a HIV-1 gp120 V3 peptide from MN strain | |
| 8XX0 | 8XX0 | Crystal structure of anti-IgE antibody HMK-12 Fab complexed with IgE F(ab')2 | |
| 6WVZ | 6WVZ | Crystal structure of anti-MET Fab arm of amivantamab in complex with human MET | |
| 6WVZ | P08581 | Crystal structure of anti-MET Fab arm of amivantamab in complex with human MET | |
| 6WYR | 6WYR | Crystal structure of anti-Muscle Specific Kinase (MuSK) Fab, MuSK1A | |
| 6WYT | 6WYT | Crystal structure of anti-Muscle Specific Kinase (MuSK) Fab, MuSK1B | |
| 5JOP | 5JOP | Crystal structure of anti-glycan antibody Fab14.22 in complex with Streptococcus pneumoniae serotype 14 tetrasaccharide at 1.75 A | |
| 3DSF | 3DSF | Crystal structure of anti-osteopontin antibody 23C3 in complex with W43A mutated epitope peptide | |
| 3DSF | P10451 | Crystal structure of anti-osteopontin antibody 23C3 in complex with W43A mutated epitope peptide | |
| 3CXD | 3CXD | Crystal structure of anti-osteopontin antibody 23C3 in complex with its epitope peptide | |
| 3CXD | P10451 | Crystal structure of anti-osteopontin antibody 23C3 in complex with its epitope peptide | |
| 3WBD | 3WBD | Crystal structure of anti-polysialic acid antibody single chain Fv fragment (mAb735) complexed with octasialic acid | |
| 7V8Q | 7V8Q | Crystal structure of antibody 14A in complex with MUC1 Glycopeptide(GlycoT) | |
| 7V8Q | P15941 | Crystal structure of antibody 14A in complex with MUC1 Glycopeptide(GlycoT) | |
| 7VAZ | 7VAZ | Crystal structure of antibody 14A in complex with MUC1 glycopeptide(GlycoS) | |
| 7VAZ | P15941 | Crystal structure of antibody 14A in complex with MUC1 glycopeptide(GlycoS) | |
| 7VAC | 7VAC | Crystal structure of antibody 14A in complex with MUC1 glycopeptide(GlycoST) | |
| 7VAC | P15941 | Crystal structure of antibody 14A in complex with MUC1 glycopeptide(GlycoST) | |
| 4GXU | Q9WFX3 | Crystal structure of antibody 1F1 bound to the 1918 influenza hemagglutinin | |
| 4GXU | 4GXU | Crystal structure of antibody 1F1 bound to the 1918 influenza hemagglutinin | |
| 6V6W | 6V6W | Crystal structure of antibody 438-B11 DSS mutant (Cys98A-100aA) in complex with an uncleaved prefusion optimized (UFO) soluble BG505 trimer and Fab 35O22 | |
| 6V6W | Q2N0S6 | Crystal structure of antibody 438-B11 DSS mutant (Cys98A-100aA) in complex with an uncleaved prefusion optimized (UFO) soluble BG505 trimer and Fab 35O22 | |
| 6V6W | Q2N0S9 | Crystal structure of antibody 438-B11 DSS mutant (Cys98A-100aA) in complex with an uncleaved prefusion optimized (UFO) soluble BG505 trimer and Fab 35O22 | |
| 6UUM | 6UUM | Crystal structure of antibody 438-B11 DSS mutant (Cys98A-Cys100aA) | |
| 6UUD | 6UUD | Crystal structure of antibody 5D5 in complex with PfCSP N-terminal peptide | |
| 7U8E | P0DTC2 | Crystal structure of antibody Ab246 in complex with SARS-CoV-2 receptor binding domain | |
| 7U8E | 7U8E | Crystal structure of antibody Ab246 in complex with SARS-CoV-2 receptor binding domain | |
| 4JB9 | 4JB9 | Crystal structure of antibody VRC06 in complex with HIV-1 gp120 core | |
| 4OLU | Q0ED31 | Crystal structure of antibody VRC07 in complex with clade A/E 93TH057 HIV-1 gp120 core | |
| 4OLU | 4OLU | Crystal structure of antibody VRC07 in complex with clade A/E 93TH057 HIV-1 gp120 core | |
| 4OLV | Q0ED31 | Crystal structure of antibody VRC07-G54F in complex with clade A/E 93TH057 HIV-1 gp120 core | |
| 4OLV | 4OLV | Crystal structure of antibody VRC07-G54F in complex with clade A/E 93TH057 HIV-1 gp120 core | |
| 4OLW | Q0ED31 | Crystal structure of antibody VRC07-G54H in complex with clade A/E 93TH057 HIV-1 gp120 core | |
| 4OLW | 4OLW | Crystal structure of antibody VRC07-G54H in complex with clade A/E 93TH057 HIV-1 gp120 core | |
| 4OLX | Q0ED31 | Crystal structure of antibody VRC07-G54L in complex with clade A/E 93TH057 HIV-1 gp120 core | |
| 4OLX | 4OLX | Crystal structure of antibody VRC07-G54L in complex with clade A/E 93TH057 HIV-1 gp120 core | |
| 4OLY | Q0ED31 | Crystal structure of antibody VRC07-G54R in complex with clade A/E 93TH057 HIV-1 gp120 core | |
| 4OLY | 4OLY | Crystal structure of antibody VRC07-G54R in complex with clade A/E 93TH057 HIV-1 gp120 core | |
| 4OLZ | Q0ED31 | Crystal structure of antibody VRC07-G54W in complex with clade A/E 93TH057 HIV-1 gp120 core | |
| 4OLZ | 4OLZ | Crystal structure of antibody VRC07-G54W in complex with clade A/E 93TH057 HIV-1 gp120 core | |
| 4OM0 | Q0ED31 | Crystal structure of antibody VRC07-G54Y in complex with clade A/E 93TH057 HIV-1 gp120 core | |
| 4OM0 | 4OM0 | Crystal structure of antibody VRC07-G54Y in complex with clade A/E 93TH057 HIV-1 gp120 core | |
| 4OM1 | Q0ED31 | Crystal structure of antibody VRC07-I30Q, G54W, S58N in complex with clade A/E 93TH057 HIV-1 gp120 core | |
| 4OM1 | 4OM1 | Crystal structure of antibody VRC07-I30Q, G54W, S58N in complex with clade A/E 93TH057 HIV-1 gp120 core | |
| 8F2X | P0DTC2 | Crystal structure of antibody WRAIR-2123 in complex with SARS-CoV-2 receptor binding domain | |
| 8F2X | 8F2X | Crystal structure of antibody WRAIR-2123 in complex with SARS-CoV-2 receptor binding domain | |
| 8SMI | P0DTC2 | Crystal structure of antibody WRAIR-2123 in complex with SARS-CoV-2 receptor binding domain | |
| 8SMI | 8SMI | Crystal structure of antibody WRAIR-2123 in complex with SARS-CoV-2 receptor binding domain | |
| 8F2J | 8F2J | Crystal structure of antibody WRAIR-2134 in complex with SARS-CoV-2 receptor binding domain |
